New Report from MGA Examines Impact of Rebates on Drug Pricing, Competition

MGA has released a new report today, “Understanding Drug Rebates and Their Role in Promoting Competition,” authored by founder and CEO Alex Brill. Offering new analysis on the potential impact of rebates on drug prices and healthy competition among drug companies, the report challenges the common misconception that rebates are to blame for the rising costs of prescription medications.

Read the full report here.